Company Overview and News
Stocks were indicated to open marginally higher on Tuesday, which would make a four-day Dow Jones industrials rally, if the gains hold. Earnings season is now about 90% of the way to its end, and more than 70% of the companies exceeded expectations. Still, investors have noted that the stock market volatility in 2018 has been less rewarding for those who have continued to buy on every dip than had been the case for several years.
HON SYMC DAVA ADP AJRD HON FN ADUS ADPVV AAPL ITW TRI EMR MS PAYX
Investors looking for stocks in the Outsourcing sector might want to consider either Convergys (CVG - Free Report) or Paychex (PAYX - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
Investors interested in Outsourcing stocks are likely familiar with Convergys (CVG - Free Report) and Paychex (PAYX - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
A prudent investment decision involves buying stocks that have solid prospects and selling those that carry risks. At times, it is rational to hold certain stocks that have enough potential but are weighed down by tough market conditions.
G FOX ALOCT ADPVV ADP ACN LMHA LMHB FOXA LM PAYX
Chicago, IL –August 13, 2018 - Stocks in this week’s article include: Paychex (PAYX - Free Report) , Luxfer Holdings (LXFR - Free Report) , WellCare Health Plans (WCG - Free Report) , Carrols Restaurant Group (TAST - Free Report) and Jacobs Engineering Group (JEC - Free Report) . Kevin Matras screens for companies showing their 'first' profit and explains why they are ones to watch.
HD EPM JEC LXFR WCG EPM-A BGSF PAYX TAST
From March through June, I wrote a series of articles that examined how far several large-cap service and financial sector stocks might fall during a bear market.
STT UNP VPU PGR FDX CCL ROST SPYR BRK.A FISV SGLRF SPGI GWW MGA MG AAPL CCL XSPY PAYX
Paylocity Holding Corporation (PCTY - Free Report) is scheduled to report fourth-quarter fiscal 2018 results on Aug 9. Notably, the company beat estimates in each of the trailing four quarters, delivering an average positive surprise of 220.08%. In the last reported quarter, the company came up with a positive earnings surprise of 10.64%. Revenues also beat the Zacks Consensus Estimate and improved year over year.
AMT PCTY OCLCF ORCL PAYX GTLS
ManpowerGroup Inc.’s (MAN - Free Report) second-quarter 2018 earnings per share (excluding restructuring cost) came in at $2.35, in line with the Zacks Consensus Estimate and within the guided range of $2.33-$2.41. The bottom line was up 29.1% on a year-over-year basis.
UPS MAN TRN IQV PAYX
Stericycle, Inc. (SRCL - Free Report) has had an impressive run on the bourse over the past three months. The stock has gained 10.9%, outperforming the 3.9% rise of the industry it belongs to. Considering strength in the company’s business-to-business services and a global acquisition strategy, we believe that the stock has the potential to continue the bull run.
WFC WFCNP UNP SRCL IQV PAYX
Genpact Limited (G - Free Report) announced yesterday that it has reached a deal to acquire leading supply chain management consultancy, Barkawi Management Consultants. Financial terms weren’t disclosed.
G IQV PAYX
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET